A share price of Thermo Fisher Scientific Inc [TMO] is currently trading at $466.71, up 9.14%. An important factor to consider is whether the stock is rising or falling in short-term value. The TMO shares have gain 12.11% over the last week, with a monthly amount glided 16.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Thermo Fisher Scientific Inc [NYSE: TMO] stock has seen the most recent analyst activity on July 11, 2025, when Scotiabank upgraded its rating to a Sector Outperform but kept the price target unchanged to $590 for it. Previously, UBS downgraded its rating to Neutral on July 09, 2025, and kept the price target unchanged to $460. On January 10, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $630 on the stock. Scotiabank started tracking the stock assigning a Sector Perform rating. Redburn Atlantic initiated its recommendation with a Buy. Stephens started tracking with a Overweight rating for this stock on October 01, 2024, and assigned it a price target of $680. In a note dated August 28, 2024, Wells Fargo initiated an Overweight rating and provided a target price of $670 on this stock.
Thermo Fisher Scientific Inc experienced fluctuations in its stock price throughout the past year between $385.46 and $627.88. Currently, Wall Street analysts expect the stock to reach $592 within the next 12 months. Thermo Fisher Scientific Inc [NYSE: TMO] shares were valued at $466.71 at the most recent close of the market. An investor can expect a potential return of 26.85% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Trailing Twelve Months sales for Thermo Fisher Scientific Inc [NYSE:TMO] were 43.21B which represents 2.98% growth. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.13 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 458.86 points at the first support level, and at 451.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 481.24, and for the 2nd resistance point, it is at 495.78.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Thermo Fisher Scientific Inc [NYSE:TMO] is 1.93. On the other hand, the Quick Ratio is 1.50, and the Cash Ratio is 0.36. Considering the valuation of this stock, the price to sales ratio is 4.08, the price to book ratio is 3.57 and price to earnings (TTM) ratio is 27.01.
Transactions by insiders
Recent insider trading involved Pettiti Gianluca, Executive Vice President, that happened on May 12 ’25 when 400.0 shares were sold. Officer, Pettiti Gianluca completed a deal on May 12 ’25 to buy 400.0 shares. Meanwhile, Executive Vice President Pettiti Gianluca sold 300.0 shares on Apr 28 ’25.
